Substrate | Metabolic Pathway | Km (μM)a | Vmax/Turnover No. (nmol/min per nmol)a |
---|---|---|---|
Endogenous | |||
Arachidonic acid | Epoxygenation | 0.065 | |
Linoleic acid | Epoxygenation | 0.105 | |
Docosahexaenoic acid | Epoxygenation (major) ω-1/ω hydroxylation (minor) | 0.228 ± 0.008 | |
Eicosapentaenoic acid | Epoxygenation (major) ω-1/ω hydroxylation (minor) | 0.943 ± 0.017 | |
Vitamin D3 | 25-Hydroxylation | 7.7 ± 1.2 | 0.087 ± 0.013 |
Vitamin D2 | 25-Hydroxylation | 2.0 ± 0.3 | 0.16 ± 0.03 |
1α(OH)D3 | 25-Hydroxylation | 4.4 ± 0.7 | 2.2 |
Drugs | |||
Albendazole | ω-Hydroxylation sulfoxidation | ||
Amiodarone | 3-Hydroxylation 4-hydroxylation | 5 | 4.6 |
Apixaban | O-demethylation | 0.27 ± 0.06 | |
Astemizolea | O-demethylation | 0.65 | 1.129 |
Benzphetamine | N-demethylation | 0.08 | |
Bufuralol | 0.17 | ||
Cyclosporine A | Hydroxylation | ||
Danazol | Hydroxylation | ||
Ebastina | Hydroxylation | 1.3/18.3 | 40.6/8.2 |
Eperisone | ω- Hydroxylation ω-1 hydroxylation | 0.0266 | |
Hydroxyebastine | Carboxylation | 0.75 | 9.86 |
Terfenadine | Hydroxylation | 0.4 | 20 |
Thioridazine | Sulfoxidation | ||
Vorapaxar | Hydroxylation | 0.0306 |
↵a Metabolic pathway used solely by CYP2J2.
b Some Km and Vmax values remain unknown.